Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • MOLECULAR INSIGHT PHARM INC Financial Overview

  • Income Statement: MIPI

      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 474,559.00 730,672.00 -256,113.00 -53.97%
    Gross Profit -428,034.00 8,785.00 -436,819.00 102.05%
    Net Income Before Extra Items/Preferred Div -81.25 M -59.83 M -21.43 M 26.37%
    Operating Income -61.92 M -57.67 M -4.24 M 6.85%
  • Cash Flow: MIPI

      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing 65,207.00 203.47 M -203.40 M -311,931.74%
    Net Cash Flow - Investing -19.70 M 105.40 M -125.10 M 635.10%
    Net Cash Flow/Operating Activities -56.38 M -44.87 M -11.51 M 20.42%
  • Balance Sheet: MIPI

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 119.18 M 176.70 M -57.52 M -48.27%
    Total Liabilities 167.00 M 148.15 M 18.85 M 11.29%
    Shareholders Equity -47.82 M 28.56 M -76.38 M 159.72%
  • Key Ratios / Statistics: MIPI

    • Valuation

      Price/Earnings (TTM) -1.32
      Price/Sales (TTM) 226.32
      Price/Book (MRQ) -1.66
      Price/Cash Flow (TTM) -2.48
    • Profitability

      Gross Margin -90.20
      Operating Margin -13,047.33
      Profit Margin -17,121.99
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 8.59
      Current Ratio (MRQ) 9.46
      Long Term Debt-to-Equity (MRQ) -210.44
    • Management Effectiveness

      Return on Equity (TTM)
      Return on Assets (TTM) -47.98
      Return on Investments (TTM) -49.30